Ionis Pharmaceuticals Inc (IONS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
7,395,202,000
EV to revenue ratio (TTM)
9.8
EV to ebitda
135.77
Financial Performance
Revenue (TTM)
874,093,000
Gross profit (TTM)
-60,603,000
EBITDA
-579,484,992
Profitability
Operating margin (TTM)
-38.20%
Profit margin
-64.70%
Return on assets (TTM)
-12.40%
Return on equity (TTM)
-105.50%
Per Share Metrics
Revenue per share (TTM)
5.36
EPS
-3.48
Diluted EPS (TTM)
-3.48
Book value
2.66
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
90.91
PEG ratio
25.7
Price to sales ratio (TTM)
8.46
Price to book ratio (TTM)
16.6
Growth
Quarterly earnings growth (YoY)
-40.70%
Quarterly revenue growth (YoY)
-43.70%
Analyst Sentiment
Strong buy
9
Buy
10
Hold
5
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.419